Severity
Critical
FDA Drug recall · Reported May 2, 2018
Labeling: Label Mix-Up: Bayer is recalling all Alka-Seltzer Plus packages, with a green or orange Bayer logo located on the lower left corner of the front of the carton, because t…
Bayer HealthCare Pharmaceuticals, Inc. recalled All Alka-Seltzer Plus¿ packages with a full front panel instant Redeemable Coupon (IRC) a… - a critical-severity action.
All Alka-Seltzer Plus¿ packages with a full front panel instant Redeemable Coupon (IRC) a… was recalled by Bayer HealthCare Pharmaceuticals, Inc. in May 2, 2018. Reason: Labeling: Label Mix-Up: Bayer is recalling all Alka-Seltzer Plus packages, with a green or orange Bayer logo …. Check the official notice for the remedy. Verify recall #D-0697-2018 with the FDA Drug before acting.
The recall
Bayer HealthCare Pharmaceuticals, Inc. issued this critical-severity FDA Drug recall-Labeling: Label Mix-Up: Bayer is recalling all Alka-Seltzer Plus packages, with a green or orange Bayer logo ….
Sourced from official FDA Drug enforcement records. Verify recall #D-0697-2018 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0697-2018) was formally reported on May 2, 2018, with the manufacturer initiating the action on March 15, 2018. It is classified under Critical severity (Class I), with a current status of Terminated. Bayer HealthCare Pharmaceuticals, Inc. is listed as the recalling firm, operating out of Whippany, NJ. Federal records list the affected scope as 188,631 units, a scale large enough to require multi-state distribution tracking.
The documented reason for this recall is: Labeling: Label Mix-Up: Bayer is recalling all Alka-Seltzer Plus packages, with a green or orange Bayer logo located on the lower left corner of the front of the carton, because the ingredients on the front sticker may … Distribution data in the federal record shows the product reached: Nationwide in the USA. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
188,631 units
Related Recalls
6
5 from same agency
All Alka-Seltzer Plus¿ packages with a full front panel instant Redeemable Coupon (IRC) affixed to the individual carton. The recalled products can be identified by checking the Bayer logo located on the lower left corner of the front of the carton. If the logo has an orange or green background, the product is included in the recall.
Labeling: Label Mix-Up: Bayer is recalling all Alka-Seltzer Plus packages, with a green or orange Bayer logo located on the lower left corner of the front of the carton, because the ingredients on the front sticker may not match the actual product in the carton.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Terminated |
| Recall number | D-0697-2018 |
| Date reported | May 2, 2018 |
| Date initiated | March 15, 2018 |
| Recalling firm | Bayer HealthCare Pharmaceuticals, Inc. |
| Firm location | Whippany, NJ |
| Affected scope | 188,631 units |
| Distribution | Nationwide in the USA |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported May 2, 2018. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.